PharmaEssentia Corporation Stock LUXEMBOURG S.E.
Stocks
261280558
US7169721047
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 47.00 USD | +4.44% |
|
+22.40% | +247.80% |
| 08-13 | PharmaEssentia Clarifies Report Projecting 2026 Revenue | MT |
| 08-12 | PharmaEssentia Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 622B 19.43B 16.78B 15.77B 14.34B 26.96B 1,858B 27.41B 185B 72.24B 930B 72.95B 71.36B 3,092B | P/E 2026 * |
60.4x | P/E 2027 * | 38.6x |
|---|---|---|---|---|---|
| Enterprise Value | 595B 18.6B 16.06B 15.1B 13.73B 25.81B 1,779B 26.24B 177B 69.16B 891B 69.83B 68.32B 2,960B | EV / Sales 2026 * |
21.4x | EV / Sales 2027 * | 15.8x |
| Free-Float |
77.98% | Yield 2026 * |
0.06% | Yield 2027 * | 0.1% |
| 1 day | +4.44% | ||
| 1 week | +22.40% | ||
| Current month | +43.29% | ||
| 1 month | +25.67% | ||
| 3 months | +110.36% | ||
| 6 months | +126.83% | ||
| Current year | +247.80% |
| 1 week | 41.2 |  | 47 |
| 1 month | 31.6 | | 47 |
| Current year | 14.05 | | 47 |
| 1 year | 13.06 | | 47 |
| 3 years | 8.49 | | 47 |
| 5 years | 7.97 | | 47 |
| 10 years | 7.97 | | 47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 2016-12-31 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 2015-10-13 |
Cheng Ku Huang
PSD | President | - | 2015-06-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
BRD | Director/Board Member | - | 2000-05-08 |
Ching-Leou Teng
CHM | Chairman | - | 2012-09-23 |
Cheng Ku Huang
BRD | Director/Board Member | - | 2015-05-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.44% | +22.40% | - | - | 19.43B | |
| -1.90% | +2.85% | +61.37% | +102.88% | 70.07B | |
| -3.21% | -4.32% | +31.19% | +59.75% | 52.87B | |
| -2.05% | -5.61% | -3.14% | +454.89% | 27.02B | |
| -1.27% | -1.57% | +46.46% | +6.09% | 23.61B | |
| +1.05% | -0.62% | -17.40% | -13.36% | 23.38B | |
| +3.81% | +20.97% | +263.48% | +552.47% | 19.43B | |
| +0.10% | +1.40% | +38.98% | -20.04% | 18.75B | |
| -0.95% | -3.52% | +20.04% | +613.01% | 15.85B | |
| +1.24% | -5.23% | +33.19% | +138.21% | 12.7B | |
| Average | +0.13% | +1.95% | +52.69% | +210.43% | 29.3B | |
| Weighted average by Cap. | -0.71% | +0.55% | +49.85% | +168.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.76B 868M 749M 704M 640M 1.2B 82.96B 1.22B 8.25B 3.23B 41.54B 3.26B 3.19B 138B | 37.08B 1.16B 1B 941M 855M 1.61B 111B 1.63B 11.02B 4.31B 55.49B 4.35B 4.26B 184B |
| Net income | 10.49B 328M 283M 266M 242M 455M 31.35B 462M 3.12B 1.22B 15.7B 1.23B 1.2B 52.17B | 16.25B 508M 439M 412M 375M 705M 48.57B 716M 4.83B 1.89B 24.32B 1.91B 1.87B 80.82B |
| Net Debt | -26.52B -829M -716M -673M -612M -1.15B -79.27B -1.17B -7.88B -3.08B -39.7B -3.11B -3.04B -132B | -34.73B -1.09B -937M -881M -801M -1.51B -104B -1.53B -10.32B -4.04B -51.97B -4.08B -3.99B -173B |
| Date | Price | Change |
|---|---|---|
| 26-08-14 | US$47.00 | +4.44% |
| 26-08-13 | US$45.00 | +0.90% |
| 26-08-12 | US$44.60 | -1.33% |
| 26-08-11 | US$45.20 | +9.71% |
| 26-08-10 | US$41.20 | +7.29% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 261280558 Stock
Select your edition
All financial news and data tailored to specific country editions
